ArticleInternational journal of women's health2025
The Impact of High-Intensity Focused Ultrasound Ablation and Laparoscopic Myomectomy on Ovarian Function in Patients with Uterine Fibroids.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To explore the value of high-intensity focused ultrasound (HIFU) ablation and laparoscopic myomectomy (LM) in the treatment of uterine fibroids. Methods: One hundred and twenty patients with uterine fibroids admitted to our hospital from October 2020 to September 2022 and were conducted a randomized controlled trial and randomly assigned to two groups, with 60 cases each. The uterine fibroid surgery group is divided into LM group and HIFU ablation group. The healthy control group consisted of 60 cases. Ovarian function evaluations were conducted at four time points before surgery, 6 months after surgery, 1 year, and 2 years. The final follow-up assessment was conducted in September 2024. The ovarian function changes and complication in HIFU and LM groups were compared. Results: The AMH levels and AFC counts of the HIFU group at 6 months after surgery were (2.39±0.35) ng/mL and (6.85±1.06), which were higher than those of the LM group (2.15±0.27) ng/mL and (6.02±0.87), respectively, with statistical differences ( Conclusion: After HIFU ablation for uterine fibroids in women aged 35-40, ovarian function was not significantly affected in the short term (6 months after surgery) and the long term (2 years after surgery). Compared to LM, HIFU ablation is more effective in treating uterine fibroids, reducing the impact on patients' ovarian function with fewer complications, and improving their quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.